Prorenoate Potassium

Preferred Label : Prorenoate Potassium;

NCIt definition : The potassium salt form of prorenoate, a steroidal aldosterone antagonist with potassium-sparing diuretic activity. Prorenoate antagonizes the activity of aldosterone at the mineralocorticoid receptor in the nephron and thereby prevents sodium reabsorption. This interferes with the sodium/potassium exchanger and causes sodium and water excretion while reducing potassium excretion.;

UNII : T2D4XUS623;

InChIKey : NLSAMWIBIQWHTK-CZKUEYQYSA-M;

CAS number : 51017-25-5; 49847-97-4;

Chemical formula : C23H31O4.K;

Details

Origin ID

C84118;

UMLS CUI

C0072213;

Currated CISMeF NLP mapping
- prorenoate potassium [MeSH concept]
- prorenoate potassium [MeSH Supplementary Concept]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- prorenoate potassium [MeSH Supplementary Concept]
- prorenoate potassium [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_free_acid_or_base_form
- Prorenoate [NCIt concept]
is_salt_form_of
- Prorenoate [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients